KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Revenue (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Revenue readings, the most recent being $33.4 million for Q4 2025.

  • On a quarterly basis, Revenue fell 23.84% to $33.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $170.2 million, a 25.06% decrease, with the full-year FY2025 number at $170.2 million, down 25.06% from a year prior.
  • Revenue hit $33.4 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $38.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $168.4 million in Q1 2022 to a low of $33.4 million in Q4 2025.
  • Median Revenue over the past 5 years was $55.8 million (2023), compared with a mean of $72.0 million.
  • Biggest five-year swings in Revenue: surged 483.45% in 2021 and later crashed 64.64% in 2023.
  • Ginkgo Bioworks Holdings' Revenue stood at $148.5 million in 2021, then plummeted by 33.81% to $98.3 million in 2022, then crashed by 64.64% to $34.8 million in 2023, then increased by 26.16% to $43.8 million in 2024, then decreased by 23.84% to $33.4 million in 2025.
  • The last three reported values for Revenue were $33.4 million (Q4 2025), $38.8 million (Q3 2025), and $49.6 million (Q2 2025) per Business Quant data.